References
- Gage BF, Fihn SD, White RH. Management and dosing of warfarin therapy. Am J Med. 2000;109:481–488.
- Pirmohamed M. Warfarin: almost 60 years old and still causing problems. Br J Clin Pharmacol. 2006;62:509–511.
- Rosendaal FR, Cannegieter SC, van der Meer FJ, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236–239.
- Connolly SJ, Pogue J, Eikelboom J, et al. ACTIVE W Investigators. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation. 2008;118:2029–2037.
- Kjeldsen J, Lassen JF, Petersen PH, et al. Biological variation of International Normalized Ratio for prothrombin times, and consequences in monitoring oral anticoagulant therapy: computer simulation of serial measurements with goal-setting for analytical quality. Clin Chem. 1997;43:2175–2182.
- CLSI. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays. Approved Guideline – 5th ed. CLSI document H21-A5. Wayne (PA): Clinical and Laboratory Standards Institute; 2008.
- CLSI. Procedures and devices for the collection of diagnostic capillary blood specimens. Approved Standard – 6th ed. CLSI document GP42-A6. Wayne (PA): Clinical and Laboratory Standards Institute; 2008.
- Owren PA. Thrombotest. A new method for controlling anticoagulant therapy. Lancet. 1959;2:754–758.
- Onelöv L, Basmaji R, Svensson A, et al. Evaluation of small-volume tubes for venous and capillary PT (INR) samples. Int J Lab Hematol. 2015;37:699–704.
- ] Lindahl TL, Egberg N, Hillarp A, et al. INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples. Thromb Haemost. 2004;91:1223–1231.
- Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;327:307–310.
- Besselaar AMHP, Witteveen E, Meer FJM. Influence of haematocrit on international normalised ratio (INR) differences between a whole blood point-of-care coagulation monitor and reference prothrombin time in plasma. Thromb Haemost. 2008;100:1181–1184.